Abstract:BACKGROUND:Clozapine has been associated with metabolic adverse events (AEs) (eg, elevated body weight, blood glucose concentrations, cholesterol, triglycerides [TG]), all of which have deleterious effects on health and medication compliance. However, little focus has been directed toward finding a suitable experimental model to study the metabolic AEs associated with clozapine.OBJECTIVE:The aim of this study was to assess the effects of clozapine administration for 28 days on body weight, glucose tolerance, blood glucose concentrations, plasma lipids, and insulin in C57BL/6 mice.METHODS:C57BL/6 mice were grouped and treated with clozapine 2 or 10 mg/kg or vehicle intraperitoneally QD for 28 days. Body weight was assessed on days 0 (baseline), 7, 14, 21, and 28, and glucose tolerance, blood glucose concentrations, insulin (calculated by insulin resistance index [IRI]), and plasma lipids (including total cholesterol, TG, high-density lipoprotein cholesterol [HDL-C], and low-density lipoprotein cholesterol) were assessed on day 29.RESULTS:Sixty 10-week-old, male C57BL/6 mice were included in the study and were divided into 3 groups (20 mice per group). The body weight significantly decreased in the clozapine 10-mg-treated group on days 14, 21, and 28 compared with the vehicle group (mean [SD] body weight: 21.61 [1.05] vs 22.79 [1.11], 22.53 [1.05] vs 24.17 [1.24], and 22.21 [1.07] vs 24.99 [1.39] g, respectively; all, P < 0.05). In the clozapine 10-mg/kg group, blood glucose concentrations significantly increased 0, 30, 60, and 120 minutes after glucose administration compared with the vehicle group (mean [SD]: 6.67 [1.25], 25.34 [5.85], 12.68 [3.39], and 7.52 [1.45] mmol/L, respectively, vs 4.61 [0.78], 21.54 [6.55], 11.46 [3.46], and 6.55 [1.42] mmol/L, respectively; all P < 0.05). The clozapine 10-mg/kg group also had significant increases in plasma insulin concentrations compared with the vehicle group (12.70 [5.27] vs 7.62 [4.54] μIU/mL; P < 0.05) and IRI (3.01 [1.26] vs 1.51 [0.96]; P < 0.05). Plasma HDL-C concentration also significantly decreased in the clozapine 10-mg/kg group compared with the vehicle group (1.23 [0.25] vs 1.47 [0.16]; P < 0.05).CONCLUSION:Clozapine 10 mg/kg was associated with significant decreases in body weight and significant increases in fasting blood glucose and glucose tolerance in these male C57BL/6 mice.

Effects of central activation of serotonin 5-HT 2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test

Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning

Effects of clozapine on the hypoglutamatergic schizophrenia model in mice

Effect of Chronic Treatment with Clozapine and Haloperidol on 5-HT2A and 2C Receptor Mrna Expression in the Rat Brain

Repeated Administration Of 5-Hydroxytryptamine 2c Agonist Mk212 Produces A Sensitization Effect Of Antipsychotic Activity

Chronic Clozapine Treatment Improves the Alterations of Prepulse Inhibition and BDNF Mrna Expression in the Medial Prefrontal Cortex That Are Induced by Adolescent Social Isolation.

Effects of Repeated Quetiapine Treatment on Conditioned Avoidance Responding in Rats

Effect of clozapine on neuregulin-1 gene expression in prefrontal cortex of schizophrenic model rats induced by dizocilpine maleate

Olanzapine and Risperidone Disrupt Conditioned Avoidance Responding by Selectively Weakening Motivational Salience of Conditioned Stimulus: Further Evidence

Chronic administration of clozapine alleviates reversal-learning impairment in isolation-reared rats.

Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine.

Differential Effects of Clozapine on Ethanol-Induced Ascorbic Acid Release in Mouse and Rat Striatum

Does Antagonism at 5-HT2A Receptors Potentiate D₂ Blockade-Induced Disruption of Conditioned Avoidance Response?

Repeated Administration of Aripiprazole Produces a Sensitization Effect in the Suppression of Avoidance Responding and Phencyclidine-Induced Hyperlocomotion and Increases D2 Receptor-Mediated Behavioral Function

Effects of Clozapine Administration on Body Weight, Glucose Tolerance, Blood Glucose Concentrations, Plasma Lipids, and Insulin in Male C57BL/6 Mice: A Parallel Controlled Study.

Olanzapine Sensitization and Clozapine Tolerance: from Adolescence to Adulthood in the Conditioned Avoidance Response Model

The effect of clozapine on mRNA expression for genes encoding G protein-coupled receptors and the protein components of clathrin-mediated endocytosis

Haloperidol and Clozapine Treatment and Their Effect on M-Chlorophenylpiperazine-Mediated Responses in Schizophrenia - Implications for the Mechanism of Action of Clozapine

Long-term Impacts of Adolescent Risperidone Treatment on Behavioral Responsiveness to Olanzapine and Clozapine in Adulthood.

Bromocriptine and clozapine regulate dopamine 2 receptor gene expression in the mouse striatum

Comparison of risperidone and clozapine effects on MK-801-induced disruption of prepulse inhibition in mice